EcoDrugPlus

Farnesyl Diphosphate Synthase

Ensembl ID : ENSBSLG00000013271
Gene Symbol: FDPS
3 Cross references
269 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSBSLG00000011660
Gene Symbol: FDFT1
3 Cross references
221 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSBSLG00000013930
Gene Symbol: FNTA
3 Cross references
222 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-A-Like

Ensembl ID : ENSBSLG00000025926
Gene Symbol: LOC114861756
3 Cross references
208 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSBSLG00000013787
Gene Symbol: FGFR2
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSBSLG00000012509
Gene Symbol: LOC114848555
3 Cross references
192 Possible Orthologues:

Fms Related Tyrosine Kinase 1

Ensembl ID : ENSBSLG00000000721
Gene Symbol: FLT1
3 Cross references
199 Possible Orthologues:

Fms Related Tyrosine Kinase 4

Ensembl ID : ENSBSLG00000009878
Gene Symbol: FLT4
3 Cross references
197 Possible Orthologues:

Folate Hydrolase 1b

Ensembl ID : ENSBSLG00000016272
Gene Symbol: FOLH1B
3 Cross references
340 Possible Orthologues:

Folate Receptor Alpha-Like

Ensembl ID : ENSBSLG00000011866
Gene Symbol: LOC114867964
3 Cross references
436 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSBSLG00000024709
Gene Symbol: FRK
2 Cross references
217 Possible Orthologues:

Galactosidase Alpha

Ensembl ID : ENSBSLG00000025288
Gene Symbol: GLA
3 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).